Funds Monitor
Fund Category Returns Trailing Annual Quarterly Monthly
groupFund CategorySortOrder1-W1-M3-M1-Y3-Y5-Y10-Y
Commodities Gold: Funds 23000.50 2.84 1.20 -10.10 -0.94 -2.15 11.46
Debt Debt: Credit Opportunities 19500.06 0.76 2.62 9.63 10.29 9.51 8.17
Debt Debt: Dynamic Bond 2050-0.04 0.64 3.11 8.51 10.55 9.28 8.27
Debt Debt: FMP 0.10 0.52 1.61 6.85 7.74 8.17 8.16
Debt Debt: Gilt Medium & Long Term 2200-0.10 0.30 3.26 9.18 11.83 9.78 8.70
Debt Debt: Gilt Short Term 21000.07 0.81 2.65 8.66 9.41 8.87 7.56
Debt Debt: Income 2000-0.01 0.63 2.82 8.55 10.10 8.92 8.12
Debt Debt: Liquid 17000.12 0.59 1.67 6.60 7.70 8.16 7.77
Debt Debt: Short Term 19000.06 0.71 2.41 8.37 9.09 8.80 8.59
Debt Debt: Ultra Short Term 18000.09 0.73 2.06 7.35 8.27 8.46 8.12
Equity Equity: Large Cap 1001.24 0.19 4.17 16.81 11.61 15.31 10.52
Equity Equity: Mid Cap 3003.01 -0.37 1.10 20.40 19.88 23.73 14.04
Equity Equity: Multi Cap 2002.10 0.14 2.85 19.22 15.37 18.14 12.37
Equity Equity: Small Cap 4003.19 -1.98 0.13 26.13 24.61 27.99 15.55
Equity Equity: Tax Planning 5002.05 -0.09 2.96 19.85 15.77 18.83 11.67
Equity|Sector Equity: Banking 8000.93 0.25 4.15 27.01 18.29 16.24 16.42
Equity|Sector Equity: FMCG 9002.75 -2.51 5.36 15.76 16.62 17.28 19.51
Equity|Sector Equity: Infrastructure 7002.70 0.18 0.57 23.44 14.39 16.08 8.03
Equity|Sector Equity: International 6000.43 0.66 4.05 6.70 2.55 5.38 6.12
Equity|Sector Equity: Pharma 10001.96 -7.71 -7.53 -13.55 6.11 14.87 15.17
Equity|Sector Equity: Technology 11002.18 1.56 3.10 3.70 5.89 15.85 8.59
Hybrid Hybrid: Arbitrage 16000.09 0.65 1.64 6.28 7.07 7.54 7.34
Hybrid Hybrid: Asset Allocation 15000.60 0.23 2.47 12.94 11.05 13.67 9.87
Hybrid Hybrid: Debt-oriented Aggressive 13000.81 0.34 2.92 11.91 11.75 12.20 10.33
Hybrid Hybrid: Debt-oriented Conservative 14000.37 0.37 2.61 9.79 10.64 10.33 9.33
Hybrid Hybrid: Equity-oriented 12001.17 0.12 2.58 13.79 13.34 16.00 10.99
Data as on Aug 17, 2017
Home | My Portfolio | ELSS | Funds | Live Events | Value Investing | Income | Insurance | Invest Now | Learn | Archive | Ask | Subscribe | About Us | Log In | Free Sign Up